DeepCure was founded to accelerate breakthrough science, developed by world-leading AI engineers, data scientists and biologists.
Our founding team includes some of the industry’s preeminent drug-discovery scientists and technologists.
Our vision is to use AI-driven discovery to create better molecules and faster cures for every disease-relevant protein target.
Location: United States, Massachusetts, Boston
Employees: 11-50
Phone: +27 63 037 2939
Total raised: $104M
Founded date: 2018
Investors 4
| Date | Name | Website |
| - | E14 Fund M... | e14fund.co... |
| - | E14 Fund | e14.vc |
| 01.06.2021 | Creative D... | creativede... |
| - | TLV Partne... | tlv.partne... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 11.04.2024 | Series A | $24M | - |
| 01.12.2022 | Series A | $40M | - |
| 08.11.2021 | Series A | $40M | - |
Mentions in press and media 13
| Date | Title | Description | Source |
| 11.04.2024 | DeepCure Closes $24M Series A-1 Funding | DeepCure, a Boston, MA-based developing novel, small molecule therapeutics powered by AI and automat... | finsmes.co... |
| 12.11.2021 | StartUPDATES: New developments from healthcare startups | Carrum Health announced the appointment of former ConsumerMedical executive Randy K. Hawkins, M.D., ... | medcitynew... |
| 09.11.2021 | DeepCure scores $40M for AI-enabled drug discovery | Photo: poba/Getty Images | mobihealth... |
| 09.11.2021 | DeepCure Closes $40M Series A Funding | DeepCure, a Boston, MA-based company developing novel, small molecule therapeutics using an AI drug ... | finsmes.co... |
| 08.11.2021 | DeepCure Gets $40M to Grow Its AI Drug Development Platform | Photo: Shutterstock Boston-based drug developer DeepCure announced Monday it raised $40 million in f... | builtinbos... |
| 08.11.2021 | Who would take venture dollars from Facebook right now? | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 08.11.2021 | DeepCure Closes $40M Series A Funding Led by Morningside Ven... | DeepCure, a leader in developing novel, small molecule therapeutics using the world’s largest AI dru... | marketscre... |
| 08.11.2021 | Who would take venture dollars from Facebook right now? | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 08.11.2021 | DeepCure Closes $40M Series A Funding Led by Morningside Ven... | – Series A financing will catalyze growth and advance novel small molecule therapeutics pipeline acr... | venturebea... |
| 08.11.2021 | DeepCure Closes $40M Series A | BOSTON, MA, DeepCure, a startup developing small molecule therapeutics, announced the closing of a... | vcnewsdail... |
Show more